Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 18, 2019

SELL
$64.17 - $84.08 $336,892 - $441,420
-5,250 Closed
0 $0
Q1 2019

Apr 10, 2019

SELL
$77.0 - $99.34 $11,550 - $14,901
-150 Reduced 2.78%
5,250 $447,000
Q4 2018

Jan 09, 2019

SELL
$83.85 - $110.34 $25,155 - $33,102
-300 Reduced 5.26%
5,400 $465,000
Q4 2018

Jan 08, 2019

BUY
$83.85 - $110.34 $8,385 - $11,034
100 Added 1.79%
5,700 $592,000
Q3 2018

Oct 10, 2018

SELL
$97.14 - $113.31 $9,714 - $11,331
-100 Reduced 1.75%
5,600 $635,000
Q2 2018

Jul 06, 2018

BUY
$74.5 - $108.91 $44,700 - $65,346
600 Added 11.76%
5,700 $592,000
Q1 2018

Apr 10, 2018

BUY
$58.36 - $83.18 $297,636 - $424,218
5,100 New
5,100 $403,000

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Curbstone Financial Management Corp Portfolio

Follow Curbstone Financial Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Curbstone Financial Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Curbstone Financial Management Corp with notifications on news.